A Study of CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-cell Acute Lymphoblastic Leukemia
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Anti-CD19 chimeric antigen receptor T cell therapy The Beijing Pregene Science and Technology Company (Primary) ; Cyclophosphamide; Fludarabine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2017 New trial record